Gastroenterology & GI Surgery

Welcome to the Mayo Clinic Gastroenterology & GI Surgery Page! With one of the largest group of digestive disease specialists in the world, Mayo Clinic has been recognized as the nation's best Gastroenterology & GI Surgery hospital by U.S. News & World Report.
Follow the page to read shared experiences, learn about clinical trials and up-to-date research, and find resources for all your gastroenterology needs. Our goal is to connect you to others, and become informed decision makers; so post a comment, share your story, own your health.

PUBLIC PAGE
Wed, Oct 28, 2015 11:58pm

‘Creeping Fat’ May Contribute to IBD

By Kanaaz Pereira, Connect Moderator, @kanaazpereira

According to new research data, published in Cellular and Molecular Gastroenterology and Hepatology, intra-abdominal fat cells may play a role in the pathophysiology of inflammatory bowel disease. Dr. David Bruining, M.D., explains the study.

Fat accumulation surrounding the inflamed intestine, (also known as 'creeping fat' or mesenteric fat), during Crohn’s disease represents a hallmark of the disease. In this study, researchers looked at mesenteric fat in terms of its response to a neurotransmitter, known as Substance P, and observed that the fat cells were likely to elicit more inflammation. Researchers also noticed striking differences between inflammatory mediators in fat cells between healthy people when compared to people with Crohn's disease and ulcerative colitis, demonstrating that 'creeping fat' cells may play a role in ulcerative colitis. These findings could mean that targeting 'creeping fa't may be a future focus of treatment for patients with inflammatory bowel disease.

Read the full study online here.

For more information about IBD, visit mayoclinic.org/IBD.

Dr. Bruining is a gastroenterologist at Mayo Clinic.

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Gastroenterology & GI Surgery page.

We'll include this text in the user's invitation.